245 related articles for article (PubMed ID: 8422222)
1. Maintenance drug treatment of panic disorder. I. Results of a prospective, placebo-controlled comparison of alprazolam and imipramine.
Schweizer E; Rickels K; Weiss S; Zavodnick S
Arch Gen Psychiatry; 1993 Jan; 50(1):51-60. PubMed ID: 8422222
[TBL] [Abstract][Full Text] [Related]
2. Maintenance drug treatment for panic disorder. II. Short- and long-term outcome after drug taper.
Rickels K; Schweizer E; Weiss S; Zavodnick S
Arch Gen Psychiatry; 1993 Jan; 50(1):61-8. PubMed ID: 8422223
[TBL] [Abstract][Full Text] [Related]
3. Clinical experiments in maintenance and discontinuation of imipramine therapy in panic disorder with agoraphobia.
Mavissakalian M; Perel JM
Arch Gen Psychiatry; 1992 Apr; 49(4):318-23. PubMed ID: 1558466
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular and symptomatic reduction effects of alprazolam and imipramine in patients with panic disorder: results of a double-blind, placebo-controlled trial.
Taylor CB; Hayward C; King R; Ehlers A; Margraf J; Maddock R; Clark D; Roth WT; Agras WS
J Clin Psychopharmacol; 1990 Apr; 10(2):112-8. PubMed ID: 2187912
[TBL] [Abstract][Full Text] [Related]
5. Double-blind, placebo-controlled study of a once-a-day, sustained-release preparation of alprazolam for the treatment of panic disorder.
Schweizer E; Patterson W; Rickels K; Rosenthal M
Am J Psychiatry; 1993 Aug; 150(8):1210-5. PubMed ID: 8328566
[TBL] [Abstract][Full Text] [Related]
6. Drug treatment of panic disorder: the comparative efficacy of imipramine, alprazolam, and trazodone.
Charney DS; Woods SW; Goodman WK; Rifkin B; Kinch M; Aiken B; Quadrino LM; Heninger GR
J Clin Psychiatry; 1986 Dec; 47(12):580-6. PubMed ID: 3536889
[TBL] [Abstract][Full Text] [Related]
7. Anxiety psychopathology predictive of outcome in patients with panic disorder and depression treated with imipramine, alprazolam and placebo.
Pollack MH; Otto MW; Sachs GS; Leon A; Shear MK; Deltito JA; Keller MB; Rosenbaum JF
J Affect Disord; 1994 Apr; 30(4):273-81. PubMed ID: 8014326
[TBL] [Abstract][Full Text] [Related]
8. Maintenance drug therapy of panic disorder.
Curtis GC; Massana J; Udina C; Ayuso JL; Cassano GB; Perugi G
J Psychiatr Res; 1993; 27 Suppl 1():127-42. PubMed ID: 8145175
[TBL] [Abstract][Full Text] [Related]
9. Three-year follow-up of patients with panic disorder after short-term treatment with alprazolam and imipramine.
Lepola UM; Rimón RH; Riekkinen PJ
Int Clin Psychopharmacol; 1993; 8(2):115-8. PubMed ID: 8345160
[TBL] [Abstract][Full Text] [Related]
10. Response of panic disorder to fixed doses of alprazolam or imipramine.
Uhlenhuth EH; Matuzas W; Glass RM; Easton C
J Affect Disord; 1989; 17(3):261-70. PubMed ID: 2529295
[TBL] [Abstract][Full Text] [Related]
11. Drug treatment of panic disorder. Comparative efficacy of alprazolam, imipramine, and placebo. Cross-National Collaborative Panic Study, Second Phase Investigators.
Br J Psychiatry; 1992 Feb; 160():191-202; discussion 202-5. PubMed ID: 1540759
[TBL] [Abstract][Full Text] [Related]
12. Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. II. Patient acceptance, side effects, and safety.
Noyes R; DuPont RL; Pecknold JC; Rifkin A; Rubin RT; Swinson RP; Ballenger JC; Burrows GD
Arch Gen Psychiatry; 1988 May; 45(5):423-8. PubMed ID: 3358644
[TBL] [Abstract][Full Text] [Related]
13. Protective effects of imipramine maintenance treatment in panic disorder with agoraphobia.
Mavissakalian M; Perel JM
Am J Psychiatry; 1992 Aug; 149(8):1053-7. PubMed ID: 1636805
[TBL] [Abstract][Full Text] [Related]
14. Avoidance behaviour: a predictor of the efficacy of pharmacotherapy in panic disorder?
Maier W; Roth SM; Argyle N; Buller R; Lavori P; Brandon S; Benkert O
Eur Arch Psychiatry Clin Neurosci; 1991; 241(3):151-8. PubMed ID: 1790160
[TBL] [Abstract][Full Text] [Related]
15. Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. I. Efficacy in short-term treatment.
Ballenger JC; Burrows GD; DuPont RL; Lesser IM; Noyes R; Pecknold JC; Rifkin A; Swinson RP
Arch Gen Psychiatry; 1988 May; 45(5):413-22. PubMed ID: 3282478
[TBL] [Abstract][Full Text] [Related]
16. Influence of depression on the treatment of panic disorder with imipramine, alprazolam and placebo.
Keller MB; Lavori PW; Goldenberg IM; Baker LA; Pollack MH; Sachs GS; Rosenbaum JF; Deltito JA; Leon A; Shear K
J Affect Disord; 1993 May; 28(1):27-38. PubMed ID: 8326078
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of alprazolam, imipramine and placebo in treating panic disorder. A Scandinavian multicenter study.
Andersch S; Rosenberg NK; Kullingsjö H; Ottosson JO; Bech P; Bruun-Hansen J; Hanson L; Lorentzen K; Mellergård M; Rasmussen S
Acta Psychiatr Scand Suppl; 1991; 365():18-27. PubMed ID: 1862730
[TBL] [Abstract][Full Text] [Related]
18. Subtyping panic disorder by major depression and avoidance behaviour and the response to active treatment.
Maier W; Rosenberg R; Argyle N; Buller R; Roth M; Brandon S; Benkert O
Eur Arch Psychiatry Clin Neurosci; 1991; 241(1):22-30. PubMed ID: 1832302
[TBL] [Abstract][Full Text] [Related]
19. The structure of phobias in panic disorder.
Argyle N; Solyom C; Solyom L
Br J Psychiatry; 1991 Sep; 159():378-82. PubMed ID: 1958949
[TBL] [Abstract][Full Text] [Related]
20. Treatment of panic disorder in older adults: a pilot study comparison of alprazolam, imipramine, and placebo.
Sheikh JI; Swales PJ
Int J Psychiatry Med; 1999; 29(1):107-17. PubMed ID: 10376237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
